5-Methyltetrahydrofolate Alleviates Memory Impairment in a Rat Model of Alzheimer’s Disease Induced by D-Galactose and Aluminum Chloride
Open Access
- 7 December 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (24) , 16426
Abstract
The effects of 5-methyltetrahydrofolate (5-MTHF) on a rat model of Alzheimer’s disease (AD) induced by D-galactose (D-gal) and aluminum chloride (AlCl3) were investigated. Wistar rats were given an i.p. injection of 60 mg/kg D-gal and 10 mg/kg AlCl3 to induce AD and three doses of 1 mg/kg, 5 mg/kg or 10 mg/kg 5-MTHF by oral gavage. A positive control group was treated with 1 mg/kg donepezil by gavage. Morris water maze performance showed that 5 and 10 mg/kg 5-MTHF significantly decreased escape latency and increased the number of platform crossings and time spent in the target quadrant for AD rats. The administration of 10 mg/kg 5-MTHF decreased the brain content of amyloid β-protein 1-42 (Aβ1-42) and phosphorylated Tau protein (p-Tau) and decreased acetylcholinesterase and nitric oxide synthase activities. Superoxide dismutase activity, vascular endothelial growth factor level and glutamate concentration were increased, and malondialdehyde, endothelin-1, interleukin-6, tumor necrosis factor-alpha and nitric oxide decreased. The administration of 10 mg/kg 5-MTHF also increased the expression of disintegrin and metallopeptidase domain 10 mRNA and decreased the expression of β-site amyloid precursor protein cleavage enzyme 1 mRNA. In summary, 5-MTHF alleviates memory impairment in a D-gal- and AlCl3-exposed rat model of AD. The inhibition of Aβ1-42 and p-Tau release, reduced oxidative stress, the regulation of amyloid precursor protein processing and the release of excitatory amino acids and cytokines may be responsible.Keywords
Funding Information
- Key Technology Research and Development Program of Shandong Province (2019GSF107002, 2021KY613, 2022RC120, LGC21H260001, ZFY-2021-K-003)
- Zhejiang Province Health Science and Technology Program (2019GSF107002, 2021KY613, 2022RC120, LGC21H260001, ZFY-2021-K-003)
- Zhejiang Province Health Science and Technology Program (2019GSF107002, 2021KY613, 2022RC120, LGC21H260001, ZFY-2021-K-003)
- Zhejiang Province Public Welfare Technology Application Research Project (2019GSF107002, 2021KY613, 2022RC120, LGC21H260001, ZFY-2021-K-003)
- Zhenan Institute of Radiation Medicine and Nuclear Technology Application Open Project (2019GSF107002, 2021KY613, 2022RC120, LGC21H260001, ZFY-2021-K-003)
This publication has 50 references indexed in Scilit:
- Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer’s diseaseClinical Interventions in Aging, 2013
- The effects of amyloid-β42 oligomer on the proliferation and activation of astrocytes in vitroIn Vitro Cellular & Developmental Biology - Animal, 2011
- Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's diseaseJournal of Neuroinflammation, 2011
- Alzheimer’s β‐amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR‐2Journal of Neurochemistry, 2009
- Activation of p38 MAPK in the substantia nigra leads to nuclear translocation of NF‐κB in MPTP‐treated mice: implication in Parkinson’s diseaseJournal of Neurochemistry, 2009
- Lipid peroxidation up‐regulates BACE1 expression in vivo: a possible early event of amyloidogenesis in Alzheimer’s diseaseJournal of Neurochemistry, 2008
- Folate: In Vitro and in Vivo Effects on VLDL and LDL OxidationInternational Journal for Vitamin and Nutrition Research, 2007
- Mechanisms Behind the Neuroprotective Actions of Cholinesterase Inhibitors in Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 2006
- Pharmacokinetic study on the utilisation of 5‐methyltetrahydrofolate and folic acid in patients with coronary artery diseaseBritish Journal of Pharmacology, 2004
- Amyloid β-peptide stimulates nitric oxide production in astrocytes through an NFκB-dependent mechanismProceedings of the National Academy of Sciences, 1998